Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Perez

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Seminars in Oncology|February 26, 2004
A review of small-molecule epidermal growth factor receptor-specific tyrosine kinase inhibitors in development for non-small cell lung cancerKatrina Y Glover, Roman Perez-Soler, Vassiliki A Papadimitradopoulou
Journal of Analytical Toxicology|January 20, 2018
Estimation of Measurement Uncertainty in Quantitation of Benzoylecgonine (BZE) and 11-nor-Δ9-THC-9-carboxylic acid (THCA)Darryl P Arfsten, Erick Roman Perez, Neal C Goebel
Current Treatment Options in Oncology|March 5, 2016
Medical Treatment in Elderly Patients with Non-Small Cell Lung CancerKamila Bakirhan, Janaki Sharma, Roman Perez-Soler, et al.
Molecular Endocrinology (Baltimore, Md.)|April 26, 2007
Cellular expression levels of the vitamin D receptor are critical to its transcriptional regulation by the pituitary transcription factor Pit-1Samuel Seoane, Isabel Ben, Viviana Centeno, et al.
The Journal of Biological Chemistry|June 25, 2003
Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cellsYi-He Ling, Leonard Liebes, Yiyu Zou, et al.
Cancer Chemotherapy and Pharmacology|January 9, 2009
Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinibYi-He Ling, Tianhong Li, Roman Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2013
Retraction: The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximabRoman Perez-Soler, Yiyu Zou, Tianhong Li, et al.
Expert Opinion on Pharmacotherapy|November 16, 2018
Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidenceDiego Adrianzen Herrera, Nadia Ashai, Roman Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2011
The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximabRoman Perez-Soler, Yiyu Zou, Tianhong Li, et al.
Expert Review of Anticancer Therapy|June 25, 2003
Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinaseAnca M Bulgaru, Sridhar Mani, Sanjay Goel, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Seminars in Oncology|February 26, 2004
A review of small-molecule epidermal growth factor receptor-specific tyrosine kinase inhibitors in development for non-small cell lung cancerKatrina Y Glover, Roman Perez-Soler, Vassiliki A Papadimitradopoulou
Journal of Analytical Toxicology|January 20, 2018
Estimation of Measurement Uncertainty in Quantitation of Benzoylecgonine (BZE) and 11-nor-Δ9-THC-9-carboxylic acid (THCA)Darryl P Arfsten, Erick Roman Perez, Neal C Goebel
Current Treatment Options in Oncology|March 5, 2016
Medical Treatment in Elderly Patients with Non-Small Cell Lung CancerKamila Bakirhan, Janaki Sharma, Roman Perez-Soler, et al.
Molecular Endocrinology (Baltimore, Md.)|April 26, 2007
Cellular expression levels of the vitamin D receptor are critical to its transcriptional regulation by the pituitary transcription factor Pit-1Samuel Seoane, Isabel Ben, Viviana Centeno, et al.
The Journal of Biological Chemistry|June 25, 2003
Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cellsYi-He Ling, Leonard Liebes, Yiyu Zou, et al.
Cancer Chemotherapy and Pharmacology|January 9, 2009
Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinibYi-He Ling, Tianhong Li, Roman Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2013
Retraction: The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximabRoman Perez-Soler, Yiyu Zou, Tianhong Li, et al.
Expert Opinion on Pharmacotherapy|November 16, 2018
Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidenceDiego Adrianzen Herrera, Nadia Ashai, Roman Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2011
The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximabRoman Perez-Soler, Yiyu Zou, Tianhong Li, et al.
Expert Review of Anticancer Therapy|June 25, 2003
Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinaseAnca M Bulgaru, Sridhar Mani, Sanjay Goel, et al.
Pageof 14